Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ladomery

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Experimental Cell Research|August 29, 2006
WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivoM Andrea Markus, Bettina Heinrich, Oleg Raitskin, et al.
BMC Cancer|April 3, 2018
Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cellsElizabeth Bowler, Sean Porazinski, Simon Uzor, et al.
Human Molecular Genetics|August 14, 2003
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosisCharles E Patek, Stewart Fleming, Colin G Miles, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 5, 2020
WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1Tareg Belali, Chigeru Wodi, Bethany Clark, et al.
Cancer Informatics|November 26, 2020
APC and AXIN2 Are Promising Biomarker Candidates for the Early Detection of Adenomas and Hyperplastic PolypsSama Rezasoltani, Mahrooyeh Hadizadeh, Mina Golmohammadi, et al.
British Journal of Cancer|June 26, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancerLing Li, Lisa Hobson, Laura Perry, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 4, 2019
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartmentAda Koschorke, Simona Faraci, Debora Giani, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Experimental Cell Research|August 29, 2006
WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivoM Andrea Markus, Bettina Heinrich, Oleg Raitskin, et al.
BMC Cancer|April 3, 2018
Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cellsElizabeth Bowler, Sean Porazinski, Simon Uzor, et al.
Human Molecular Genetics|August 14, 2003
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosisCharles E Patek, Stewart Fleming, Colin G Miles, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 5, 2020
WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1Tareg Belali, Chigeru Wodi, Bethany Clark, et al.
Cancer Informatics|November 26, 2020
APC and AXIN2 Are Promising Biomarker Candidates for the Early Detection of Adenomas and Hyperplastic PolypsSama Rezasoltani, Mahrooyeh Hadizadeh, Mina Golmohammadi, et al.
British Journal of Cancer|June 26, 2020
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancerLing Li, Lisa Hobson, Laura Perry, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 4, 2019
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartmentAda Koschorke, Simona Faraci, Debora Giani, et al.
Pageof 3